Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
Na ZhangMengtao LiJunyan QianQian WangJiuliang ZhaoZhenwen YangZhuang TianXiao ZhangXiaoxia ZuoMiaojia ZhangJianli JiangShuang YeWei ZhangYi ZhengWufang QiYang LiZhuoli ZhangFeng DingJieruo GuYi LiuWei WeiXiaofeng ZengPublished in: International journal of rheumatic diseases (2019)
Overall, we recommend performing early screening using TTE in SLE patients with serositis, anti-RNP antibodies, or a DLCO/%Pred <70%, even for patients in a relatively stable condition according to SLE disease activity index.
Keyphrases
- disease activity
- systemic lupus erythematosus
- pulmonary arterial hypertension
- rheumatoid arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- risk factors
- end stage renal disease
- juvenile idiopathic arthritis
- pulmonary artery
- ejection fraction
- pulmonary hypertension
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors